Compare INUV & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INUV | FEMY |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 51.5M |
| IPO Year | N/A | 2021 |
| Metric | INUV | FEMY |
|---|---|---|
| Price | $2.56 | $0.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $14.00 | $6.83 |
| AVG Volume (30 Days) | 105.1K | ★ 1.3M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $98,139,861.00 | $2,061,502.00 |
| Revenue This Year | $20.86 | $64.02 |
| Revenue Next Year | $14.59 | $147.19 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 25.11 | ★ 63.53 |
| 52 Week Low | $2.34 | $0.31 |
| 52 Week High | $7.90 | $1.80 |
| Indicator | INUV | FEMY |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 39.66 |
| Support Level | $2.50 | $0.70 |
| Resistance Level | $2.77 | $0.89 |
| Average True Range (ATR) | 0.17 | 0.07 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 11.65 | 4.69 |
Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.